Analyst Reco. Embecta Corp.

Equities

EMBC

US29082K1051

Market Closed - Nasdaq Other stock markets 15:59:50 2024-05-03 EDT			5-day change	1st Jan Change
10.14 ^USD	-0.88%		-1.65%	-46.43%

02-09	Sector Update: Health Care Stocks Mixed Pre-Bell Friday	MT
02-09	Sector Update: Health Care	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Adjusts Price Target on to $16 From $15, Maintains Underweight Rating	11-22	MT
Morgan Stanley Adjusts Price Target on Embecta to $15 From $16, Maintains Underweight Rating	23-10-18	MT
BofA Trims Price Target on Embecta to $17 From $25, Keeps Underperform Rating	23-10-18	MT
Morgan Stanley Trims Price Target on Embecta to $16 From $19, Maintains Underweight Rating	23-08-24	MT
Morgan Stanley Adjusts Price Target on Embecta to $19 From $29, Maintains Underweight Rating	23-07-18	MT
Morgan Stanley Downgrades Embecta to Underweight From Equalweight, Price Target is $28	23-01-06	MT
Morgan Stanley Adjusts Price Target on Embecta to $31 From $33, Maintains Equal-Weight Rating	22-12-21	MT
Morgan Stanley Adjusts Price Target on Embecta Corp. to $33 From $36, Reiterates Equalweight Rating	22-10-11	MT
BTIG Initiates Embecta at Neutral	22-09-08	MT
Morgan Stanley Adjusts Price Target on Embecta to $36 From $33, Keeps Equalweight Rating	22-08-16	MT
Morgan Stanley Initiates Embecta at Equalweight with $33 Price Target	22-08-01	MT
BofA Securities Initiates Embecta at Underperform with $25 Price Target	22-06-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer